Treatment of anemia in Patient Blood Management from an economic perspective;Tratamiento de la anemia en el «Patient Blood Management» desde una perspectiva económica

Revista Espanola de Anestesiologia y Reanimacion

Volumn 62, Issue S1, 2015, Pages 80-85

  Bisbe Vives, E ^a  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

Anemia; Savings; Transfusion

Indexed keywords

ANTIANEMIC AGENT; ERYTHROPOIETIN; IRON; RECOMBINANT PROTEIN;

ADVERSE EFFECTS; ANEMIA; BLOOD BANK; BLOOD EXAMINATION; BLOOD TRANSFUSION; COST BENEFIT ANALYSIS; COST CONTROL; ECONOMICS; HOSPITAL COST; HUMAN; OPERATIVE BLOOD LOSS; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATIONS; RISK; UTILIZATION;

ANEMIA; BLOOD BANKS; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; COST SAVINGS; COST-BENEFIT ANALYSIS; ERYTHROPOIETIN; HEMATINICS; HEMATOLOGIC TESTS; HOSPITAL COSTS; HUMANS; IRON; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RECOMBINANT PROTEINS; RISK;

EID: 84940094349     PISSN: 00349356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0034-9356(15)30013-X     Document Type: Article

References (24)

1. Pape A., Stein P., Horn O., Habler O. Clinical evidence of blood transfusion effectiveness. Blood Transfus 2009, 7:250-258.
2. Marik P.E., Corwin H.L. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med 2008, 36:2267-2274.
3. Glance L.G., Dick A.W., Mukamel D.B., Fleming F.J., Zollo R.A., Wissler R., et al. Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology 2011, 114:283-292.
4. Wu W.C., Schifftner T.L., Henderson W.G., Eaton C.B., Poses R.M., Uttley G., et al. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 2007, 297:2481-2488.
5. Gombotz H., Rehak P.H., Shander A., Hofmann A. Blood use in elective surgery: the Austrian benchmark study. Tranfusion 2007, 47:1468-1480.
6. Bennett-Guerrero E., Zhao Y., O'Brien S.M., Ferguson T.B.Jr., Peterson E.D., Gammie J.S., et al. Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA 2010, 304:1568-1575.
7. Kacher S., Frick K.D., Tobian A.A. The cost of transfusion:economic evaluations in transfusion medicine.Part 1. Transfusion 2013, 53:1383-1385.
8. Shander A., Hofmann A., Ozawa S., Theusinger O.M., Gombotz H., Spahn D.R. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010, 50:753-765.
9. Bolton-Maggs P.H., Cohen H. Serious Hazards Of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety. Br J Hematol 2013, 163:303-314.
10. Sabaté S., Mases A., Guilera N., Canet J., Castillo J., Orrego C., et al. ANESCARDIOCAT Group. Incidence and predictors of major perioperative adverse cardiac and cerebrovascular events in non-cardiac surgery. Br J Anaesth 2011, 107:879-890.
11. Carson J.L., Carless P.A., Hebert P.C. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2012, 4:CD002042.
12. Morton J., Anastassopoulos K.P., Patel S.T., Lerner J.H., Ryan K.J., Goss T.F., et al. Frequency and outcomes of blood products transfusion across procedures and clinical conditions warranting inpatient care: an analysis of the 2004 healthcare cost and utilization project nationwide inpatient sample database. Am J Med Qual 2010, 25:289-296.
13. Van der Poel CL, Janssen MP, Behr-Gross ME. The collection, testing and use of blood and blood components in Europe 2008 report. Strasbourg 2011.
14. Transfus Med 1994, 4:251-268. Use of blood products for elective surgery in 43 European hospitals. The Sanguis Study Group.
15. Gombotz H., Rehak P.H., Shander A., Hofmann A. The second Austrian benchmark study for blood use in elective surgery: results and practice change. Transfusion 2014, 54:2646-2657.
16. Abraham I., Sun D. The cost of blood transfusion in Western Europe as estimated from six studies. Transfusion 2012, 52:1983-1988.
17. Freedman J., Luke K., Escobar M., Vernich L., Chiavetta J.A. Experience of a network of transfusion coordinators for blood conservation (Ontario Transfusion Coordinators [ONTraC]). Transfusion 2008, 48:237-250.
18. Freedman J. The ONTraC Ontario program in blood conservation. Transfus Apher Sci 2014, 50:32-36.
19. Hofmann A., Ozawa S., Farrugia A., Farmer S.L., Shander A. Economic considerations on transfusion medicine and patient blood management. Best Pract Res Clin Anaesthesiol 2013, 27:59-68.
20. Kotzé A., Carter L.A., Scally A.J. Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. Br J Anaesth 2012, 108:943-952.
21. Enko D., Wallner F., Von-Goedecke A., Hirschmugl C., Auersperg V., Halwachs-Baumann G. The impact of an algorithm-guided management of preoperative anemia in perioperative hemoglobin level and transfusion of major orthopedic surgery pateints. Anemia 2013, 2013:641876.
22. Calvet X., Gené E., Ruíz M.A., et al. El uso de carboximaltosa de hierro reduce costes cuando se compara con hierro sacarosa o hierro oral en el tratamiento preoperatorio de la anemia ferropénica en pacientes con cáncer de colon Estudio de minimización de costes. Gastroenterol Hepatol 2014, 37:208. (Abs 128).
23. Bisbe E., García-Erce J.A., Díez-Lobo Muñoz M. Anaemia Working FGroup España. A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery. Br J Anaesth 2011, 107:477-478.
24. Muñoz M., Gómez-Ramírez S., Martín-Montañez E., Naveira E., Seara J., Pavía J. Cost of post-operative intravenous iron therapy in total lower limb arthroplasty: a retrospective, matched cohort study. Blood Transfus 2014, 12:40-49.